Lps2: A new locus required for responses to lipopolysaccharide, revealed by germline mutagenesis and phenotypic screening

Journal of Endotoxin Research

Volumn 9, Issue 4, 2003, Pages 250-255

  Hoebe, Kasper ^a   Du, Xin ^a   Goode, Jason ^a   Mann, Navjiwan ^a   Beutler, Bruce ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; DNA; ETHYLNITROSOUREA; GENE PRODUCT; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; PEPTIDOGLYCAN; RECEPTOR PROTEIN; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

ALLELE; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA METHYLATION; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC CODE; GENETIC SCREENING; GERM LINE; KNOCKOUT GENE; MACROPHAGE; MALE; MOUSE; MUTAGENESIS; NONHUMAN; PHENOTYPE; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD14; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; ETHYLNITROSOUREA; FEMALE; GENETIC SCREENING; GERM-LINE MUTATION; INBREEDING; LIPID A; LIPOPOLYSACCHARIDES; MACROPHAGE ACTIVATION; MACROPHAGES, PERITONEAL; MALE; MICE; MICE, INBRED C57BL; MUTAGENESIS; MUTAGENS; PHENOTYPE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MAMMALIA;

EID: 0038448236     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805103225001459     Document Type: Article

References (30)

1. Brown SD, Peters J. Combining mutagenesis and genomics in the mouse - closing the phenotype gap. Trends Genet 1996; 12: 433-435.
2. Hrabe de Angelis M, Balling R. Large scale ENU screens in the mouse: genetics meets genomics. Mutat Res 1998; 400: 25-32.
3. Justice MJ, Noveroske JK, Weber JS, Zheng B, Bradley A. Mouse ENU mutagenesis. Hum Mol Genet 1999; 8: 1955-1963.
4. Brown SD, Balling R. Systematic approaches to mouse mutagenesis. Curr Opin Genet Dev 2001; 11: 268-273.
5. Poltorak A, Smirnova I, He XL et al. Genetic and physical mapping of the Lps locus - identification of the Toll-4 receptor as a candidate gene in the critical region. Blood Cells Mol Dis 1998; 24: 340-355.
6. Poltorak A, He X, Smirnova I et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
7. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433.
8. Haziot A, Ferrero E, Kontgen F et al. Resistance to endotoxin shock and reduced dissemination of Gram-negative bacteria in CD14-deficient mice. Immunity 1996; 4: 407-414.
9. Shimazu R, Akashi S, Ogata H et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med 1999; 189: 1777-1782.
10. Nagai Y, Akashi S, Nagafuku M et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat Immunol 2002; 3: 667-672.
11. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 1999; 11: 115-122.
12. Suzuki N, Suzuki S, Duncan GS et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature 2002; 416: 750-756.
13. Lomaga MA, Yeh WC, Sarosi I et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999; 13: 1015-1024.
14. Moore RN, Goodrum KJ, Berry LJ. Mediation of an endotoxic effect by macrophages. J Reticuloendothel Soc 1976; 19: 187-197.
15. Michalek SM, Moore RN, McGhee JR, Rosenstreich DL, Mergenhagen SE. The primary role of lymphoreticular cells in the mediation of host responses to bacterial endotoxin. J Infect Dis 1980; 141: 55-63.
16. Freudenberg MA, Keppler D, Galanos C. Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect Immun 1986; 51: 891-895.
17. Beutler B, Milsark IW, Cerami A. Passive immunization against cachectin/tumor necrosis factor (TNF) protects mice from the lethal effect of endotoxin. Science 1985; 229: 869-871.
18. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999; 274: 10689-10692.
19. Garrelds IM, Zijlstra FJ, Tak CJAM, Bonta IL, Beckmann I, Ben-Efraim S. A comparison between two methods for measuring tumor necrosis factor in biological fluids. Agents Actions 1993; 38 (Suppl. C): C89-C91.
20. Heppner G, Weiss DW. High susceptibility of strain A mice to endotoxin and endotoxin-red blood cell mixtures. J Bacteriol 1965; 90: 696-703.
21. Watson J, Riblet R. Genetic control of responses to bacterial lipopolysaccharides in mice. I. Evidence for a single gene that influences mitogenic and immunogenic responses to lipopolysaccharides. J Exp Med 1974; 140: 1147-1161.
22. Coutinho A, Meo T. Genetic basis for unresponsiveness to lipopolysaccharide in C57BL/10Cr mice. Immunogenetics 1978; 7: 17-24.
23. Fitzgerald KA, Palsson-McDermott EM, Bowie AG et al. Ma1 (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature 2001; 413: 78-83.
24. Horng T, Barton GM, Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat Immunol 2001; 2: 835-841.
25. Adachi O, Kawai T, Takeda, K et al. Targeted disruption of the MyD88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 1998; 9: 143-150.
26. Hemmi H, Takeuchi O, Kawai T et al. A Toll-like receptor recognizes bacterial DNA. Nature 2000; 408: 740-745.
27. Hemmi H, Kaisho T, Takeuchi O et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 2002; 3: 196-200.
28. Lomaga MA, Henderson JT, Elia AJ et al. Tumor necrosis factor receptor-associated factor 6 (TRAF6) deficiency results in exencephaly and is required for apoptosis within the developing CNS. J Neurosci 2000; 20: 7384-7393.
29. Xu Y, Tao X, Shen B et al. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 2000; 408: 111-115.
30. Rosenstreich D, Vogel SN, Jacques AR, Wahl LM, Oppenheim JJ. Macrophage sensitivity to endotoxin. Genetic control by a single codominant gene. J Immunol 1978; 121: 1664-1670.